Crown Electrokinetics Corp.

CRKN Basic Materials Specialty Chemicals

Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

0.00 0.01 −100.00%
Market cap
$5.8M
P/E
0.0×
Fwd P/E
0.3×
Dividend yield
—
F-score
n/a
Altman Z
52.49
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 96.41%

Capital & Financial Ratios $m

Market Cap 5.80
Revenue 21.79
Net Income (31.02)
Free Cash Flow (34.26)
Net Debt (21.83)
Current Ratio 5.11 (at or above 1.5: strong)
Debt/Equity 0.02 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E 0.27
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth 80,945.75% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2022 2023 2024 Q'25
Cash 1 1 14 22
Receivables — 0 5 5
Inventory — — — —
Other 1 — 2 3
1 2 24 31
2022 2023 2024 Q'25
Payables 1 2 5 4
ST’ Debt — — — —
Other 2 1 1 1
5 4 11 6

Compound Annual Growth %

10y 5y 3y
Sales — — 239.20%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 6.04% 247.52%

Revenue $m

Mar Jun Sep Dec Year
’26 3 — — — —
’24 1 5 8 6 20
’23 0 0 — 0 0
’20 — — — 0 0
’19 — — — — 1
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (11) — — — —
’24 (3) (6) (3) (6) (18)
’23 (5) (4) (3) (4) (16)
’22 — (2) (2) (3) (11)
’22 (4) (3) (2) (3) (11)
’21 (3) 0 (2) (1) (7)
’20 (1) — — — (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (13) — — — —
’24 (3) (6) (5) (10) (24)
’23 (5) (4) (4) (5) (18)
’22 — (3) (2) (4) (12)
’22 (4) (3) (3) (3) (11)
’21 (4) 0 (2) (1) (8)
’20 (1) — — — (1)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (5.79) — — — —
’24 (2.90k) (879.10) (188.06) 3.33k (548.26)
’23 (10.69k) (401.43k) (20.94k) 525.82k (106.56)
’22 — (36.08k) (24.05k) (12.03k) (109.58k)
’22 (0.29) (0.38) (0.39) — (49.45)
’21 (1.70) (1.81) (0.67) (0.45) (4.60)
’20 (0.26) — — (0.25) (2.33)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Trend 2025e 2026e 2027e
Price, $
Price, $ Low — — — — — 2,065,613.63 3,186,175.25 67,503.71 2,612.25 18.30

Analyst estimates 2025–2027

Powerpack
High — — — — — 40,502,228.00 36,452,004.00 5,251,654.00 810,044.56 13,500.01
People
People Employees — — — — — 11 16 16 12 65
Revenue/emp, $m — — — 0.00 0.00 0.01 0.00 0.00 0.01 0.30
Income, $m
Income, $m Revenue — — — 1 1 0 — — 0 20
Gross margin, % — — — (21.63) (21.63) (520.00) 0.00 0.00 (510.46) (3.62)
EBT — — — (4) (5) (10) (41) (14) (29) (26)
EBT margin, % — — — (850.99) 0.00 (9,603.90) 0.00 0.00 (18,943.79) (131.70)
Net income — — 0 (4) 0 (10) 0 (14) (29) (26)
Depreciation — — — 1 1 1 3 1 11 3
Per share, $
Per share, $ Revenue — — — 0.00 0.05 0.02 0.00 0.00 0.56 0.33
Earnings — — — (8.05) (0.40) (2.33) (4.60) (109,579.30) (106.56) (548.26)
Cash flow — — — 0.00 0.00 (0.25) (0.74) 0.00 (59.40) (0.31)
Capex — — — 0.00 0.00 (0.01) (0.18) 0.00 (7.99) (0.10)
Free cash flow — — — 0.00 0.00 (0.26) (0.93) 0.00 (67.39) (0.41)
Book value — — — 0.00 (0.32) (1.69) 0.00 0.00 17.19 0.38
Shares, m — — — 0 11 4 9 0 0 59
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 — — 0.04 0.00
P/S — — — 0.00 0.00 0.00 — — 3,691.35 64.12
P/B — — — 0.00 0.00 0.00 — — 199.68 56.79
EV/Sales — — — 0.00 0.00 0.00 — — 3,688.57 63.46
EV/FCF — — — 0.00 0.00 0.00 — — (50.91) (51.39)
Cash, $m
Cash, $m Operating cash flow — — — (2) 9 (1) (7) (11) (16) (18)
Capex — — — 0 0 0 (2) (1) (2) (6)
Free cash flow — — — (2) 9 (1) (8) (12) (18) (24)
Balance, $m
Balance, $m Working capital — — — (4) 0 (7) 6 (3) (2) 13
Total debt — — — 0 2 3 0 1 — 1
Net debt — — — 0 0 0 (6) (1) (1) (13)
Shareholders’ equity — — — (3) (3) (7) 9 1 5 22
Returns, %
Returns, % ROA — — — (729.34) (2,086.22) (3,018.67) 0.00 (218.06) (368.06) (145.89)
ROIC — — — 0.00 0.00 0.00 0.00 0.00 (333.54) (163.47)
ROE — — — 220.51 0.00 185.49 0.00 (2,711.32) (1,139.24) (241.21)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2024 · latest quarter Mar 2025

Charts ten years each

Crown Electrokinetics Corp. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
LOOP Loop Industries, Inc. $18.0M — (loss-making) — (loss-making) −98.34% (below 0%: shrinking) n/m +60.46% (above 0%: growing) 0.00% (1,463.69%) Compare
TSEOQ Trinseo PLC $9.5M — (loss-making) — (loss-making) +7.79% (above 0%: growing) n/m −4,036.67% (below 0%: shrinking) 11.79% 0.01% Compare
BON Bon Natural Life Limited $9.2M 0.9× 4.5× +20.95% (above 0%: growing) −14.29% (below 0%: shrinking) −260.38% (below 0%: shrinking) 33.34% 0.00% Compare
YMAT J-Star Holding Co., Ltd $6.1M — — — — — — — Compare
CRKN Crown Electrokinetics Corp. $5.8M — (loss-making) 0.3× +306.45% (above 0%: growing) n/m −362.52% (below 0%: shrinking) (36.69%) (357.14%)
SNES Senestech, Inc. $3.8M — (loss-making) — (loss-making) +23.20% (above 0%: growing) n/m −42.77% (below 0%: shrinking) 73.64% (241.82%) Compare
BGLC BioNexus Gene Lab Corp. $3.6M — (loss-making) — −96.63% (below 0%: shrinking) n/m +44.32% (above 0%: growing) 17.06% (342.78%) Compare
CNEY CN Energy Group. Inc. $3.3M 2.3× 1.1× −99.90% (below 0%: shrinking) +33.33% (above 0%: growing) −113.57% (below 0%: shrinking) 3.28% 0.00% Compare
HGAS Global Gas Corporation $1.1M — (loss-making) — — n/m −333.93% (below 0%: shrinking) 100.00% 0.00% Compare
Median of peers $4.9M — — −44.42% — −113.57% 17.06% 0.00%

All 60 Specialty Chemicals stocks →

Crown Electrokinetics Corp. (CRKN) key facts

  • Strength: Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023.
  • Crown Electrokinetics Corp. (CRKN) is a Specialty Chemicals company in the Basic Materials sector.
  • Return on equity was −241.2% and debt-to-equity 0.02.
  • Its Altman Z-score is 52.49 (safe zone) for fiscal 2024.

Source: company filings (standardised) and stockrow calculations.

Crown Electrokinetics Corp. (CRKN) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/CRKN · Data as of Mar 31, 2025 · For information only; not investment advice. · © 2026 stockrow.com